The board of directors of Hon Corporation Limited announced that Mr. Xu Tianduo has tendered his resignation as an executive Director of the Company with effect from 20 January 2021 as he would like to devote more time and dedication on project development and management of the various People's Republic of China subsidiaries under the Group. Mr. Xu has confirmed that he had no disagreement with the Board and there was no other matters relating to his resignation that need to be brought to the attention of the shareholders of the Company or The Stock Exchange of Hong Kong Limited. The Board announced that Mr. Hui Lianwang has been appointed as an executive Director with effect from 20 January 2021. Mr. Hui, aged 42, has studied medical program at Shijiazhuang Bethune School of Medicine and graduated in July 1999. Mr. Hui has been qualified as a doctor by Shijiazhuang Health Bureau in July 1999 and possesses extensive experience in the medical and pharmaceutical industries. He has set up multiple pharmaceutical factories, developed and produced more than 30 kinds of medical products.